BDX
NYSE
$154.50
Becton Dickinson & Company (BDX)
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Buy
Target: $179.36 (+16.09%)
Market Cap
$43B
Forward P/E
11.72
P/E Ratio
46.93
Free Cash Flow Yield
-0.24%
Price Chart
Valuation
Market Cap$43B
P/E46.93
Forward P/E11.72
PEG1.11
P/S1.87
P/B1.76
Profitability
Total Revenue (TTM)$22B
Gross Profit (TTM)$10B
EBITDA$4.85B
Profit Margin-6.6%
Operating Margin2%
EPS$3.30
Financial Health
Debt-to-Equity71.6%
Free Cash Flow Yield-0.24%
Dividend Yield2.61%
Growth & Risk
EPS 5Y CAGR-6.55%
Revenue 5Y CAGR+4.46%
Dividends 5Y CAGR+12.64%
Beta (5Y)0.45
Sharpe Ratio0.39